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Abstract
Background: Zambia has taken lead in implementing integrated malaria control so as to attain the
National Health Strategic Plan goal of "reducing malaria incidence by 75% and under-five mortality
due to malaria by 20% by the year 2010". The strategic interventions include the use of long-lasting
insecticide-treated nets and indoor residual spraying, the use of artemisinin-based combination
therapies (ACT) for the treatment of uncomplicated malaria, improving diagnostic capacity (both
microscopy and rapid diagnostic tests), use of intermittent presumptive treatment for pregnant
women, research, monitoring and evaluation, and behaviour change communication. Financial
barriers to access have been removed by providing free malaria prevention and treatment services.
Methods: Data involving all under-five children reporting at the health facility in the first quarter
of 2008 was evaluated prospectively. Malaria morbidity, causes of non-malaria fever, prescription
patterns treatment patterns and referral cases were evaluated
Results: Malaria infection was found only in 0.7% (10/1378), 1.8% (251378) received anti-malarial
treatment, no severe malaria cases and deaths occurred among the under-five children with fever
during the three months of the study in the high malaria transmission season. 42.5% (586/1378) of
the cases were acute respiratory infections (non-pneumonia), while 5.7% (79/1378) were
pneumonia. Amoxicillin was the most prescribed antibiotic followed by septrin.
Conclusion:  Malaria related OPD visits have reduced at Chongwe rural health facility. The
reduction in health facility malaria cases has led to an increase in diagnoses of respiratory infections.
These findings have implications for the management of non-malaria fevers in children under the
age of five years.
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Background
Malaria accounts for 50% of outpatient attendances and
20% admissions in Africa [1]. In sub-Saharan Africa
alone, annual malaria deaths are estimated at 1.3 million
for all age groups. This has resulted into high expenditures
on malaria control. WHO estimates show that countries
may spend more than 40% of their health budget on
malaria treatment and prevention [2]. This increase in
health care expenditure and the negative effects of malaria
on productivity slows down economic growth for these
countries [3]. Not only does malaria have a negative
impact on economic growth at national level [4], but it
also affects the income levels of poor households [5].
Thus, integrated malaria control is high on the health
agenda, as described in the Abuja declaration of 2000 [6].
In Zambia, malaria accounts for about 4 million cases
(confirmed and unconfirmed) with approximately 6,400
deaths reported at health facilities country-wide [7]. The
case fatality rates among hospital admissions are esti-
mated to be 40/1,000 [8]. It is for this reason that malaria
has taken centre stage in the National Health Strategic
Plan (2006) and the fifth National Development Plan
(2006). The main goal for malaria control is "to reduce
malaria incidence by 75% and under-five mortality due to
malaria by 20% by the year 2010" [9].
In order to achieve these goals, the Ministry of Health
through the national malaria control programme is
implementing integrated malaria control. The strategic
interventions include the use of long-lasting insecticide-
treated nets and indoor residual spraying, the use of
artemisinin-based combination therapies (ACT) for the
treatment of uncomplicated malaria, improving diagnos-
tic capacity (both microscopy and rapid diagnostic tests),
encouraging the use of intermittent presumptive treat-
ment for pregnant women, research, monitoring and eval-
uation, and behaviour change communication. Financial
barriers to access have been addressed, all malaria services
(treatment and prevention) are offered free-of-charge. In
April 2006, the government removed user fees in all 56
rural districts of Zambia [10].
All these interventions are known to be effective tools for
malaria control. Further, studies in South Africa showed
that ACT has the potential to reduce expenditure on
malaria treatment [11]. Studies conducted elsewhere have
demonstrated that both IRS and ITNs are effective preven-
tion strategies in various settings [12-14]. In country stud-
ies have shown that ACT is a cost-effective treatment for
malaria [15,16]. Utzinger and colleagues demonstrated
that integrated malaria control resulted into better health
for the community and higher productivity for the mining
sector on the copperbelt in Zambia [17].
The Malaria indicator survey for 2008 report indicates that
75% Zambians own at least one ITN, 62% women
received two or more doses of IPT, more than 77% of
households in IRS designated districts were sprayed
[18,19]. Further, in a health facility survey conducted in
104 health facilities in Zambia, it was found that 60% of
the health facilities used ACT (artemether-lumefantrine),
73% had diagnostic capacity and at least 42% of children
with uncomplicated malaria were treated with ACT [20].
An assessment on the impact of user fees removal on
health facility utilisation found that from 2006 to 2007,
there was an increase in utilisation of rural health facilities
in the order of 7% and 55% for under-five and over-five
years populations respectively [10]. Thus, both the popu-
lation and health facility surveys have shown that malaria
control interventions are reaching the service delivery
points and the community members are having access.
The malaria control programme has received financial
and technical support from various multilateral, bilateral
and private organisations.
In as much as evidence on process and outcome indicators
exists, there has been less documentation of the impact of
scaling-up malaria control in Zambia. As a result, a pro-
spective study on the impact of scaling up malaria control
is being conducted in various sites. This paper presents a
case study of one particular rural district in Zambia where
malaria control has began to show positive results at
health facility level.
Methods
Study sites
The study was conducted in Chongwe district at Chongwe
rural referral health centre. Chongwe district is located 35
Km from Lusaka city. This rural district has a population
of 170,943 inhabitants. Most of the inhabitants are sub-
sistence farmers. The district was among the first seven
districts to pioneer use of ACT in 2003. In 2006, 31,322
people from 6,417 households were protected by IRS,
while in 2007 the number of people protected with IRS
was 63,307 (15,398 households). The total number of
ITNs distributed in 2007 was 26,603. Chongwe rural
health centre is a sentinel site for malaria information sys-
tem and drug efficacy monitoring. The catchment area for
Chongwe has also been selected as a site for demographic
site surveillance.
Study design and population
The study is part of a larger prospective evaluation of the
impact of scaling up malaria control on health facility dis-
ease morbidity and mortality. All children aged five years
and below who reported to Chongwe rural health facility
with fever (or history of fever) from December 2007 to
February 2008 were included in the study. All the children
were screened by either a nurse or clinical officer on duty.Malaria Journal 2009, 8:49 http://www.malariajournal.com/content/8/1/49
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Confirmation of malaria infection was performed by
either RDT or microscopy, when RDT was used, a micros-
copy slide was taken for validation. Treatment of malaria
patients was based on the treatment guidelines for malaria
in Zambia [21].
The health workers involved in patient management
included a nurse, a clinical officer, a laboratory technolo-
gist, dispenser and information officer. A community
health worker was always available to assist with patient
tracking and informed consent. The site was supervised by
a team of two scientific officers and two medical doctors
from Central and district level.
Non-malaria fevers were further investigated based on
standard treatment guidelines for Zambia. All the drugs
were supplied through routine mechanisms (Central
Medical Stores) based on the essential medicines list for
the country.
Study procedures
The health workers at the health facility received an orien-
tation prior on the commencement of the study on
malaria treatment guidelines. Emphasis was placed on
management of fever in children and more so the impor-
tance of management of non-malaria fevers. The district
clinical care specialist and the health information officer
were part of the team trained for the study. This was to
enable them provide onsite supervision for both patient
management and data management. No other interven-
tions were applied.
All under-five children reporting to the out-patient depart-
ment (OPD) of the health centre were identified and
referred to the study screening room. A clinical officer or
nurse then assessed the patient and performed a RDT test.
Further management of the patient was based on the test
result of the RDT. A microscopy slide was then taken for
comparison reading by a laboratory technician on site. A
sample of the slides was then taken to central level for
quality assurance.
The patients were followed up on days 3, 7 and 14. The
mothers were then requested to return to the health facil-
ity should the child develop any illness after that. Com-
munity health workers continued follow-up in the
community to ensure that the children were not kept at
home in case they fell sick.
Treatment
The health facility receives a health centre drug kit from
central medical stores. The drug kit contains all the drugs
and supplies required for health service delivery for a sec-
ond level health centre. All drugs are provided free to the
patients. This is because the basic health care package in
Zambia is free and, further, all rural health centres do not
charge user fees as per policy recommendation [10]. The
health worker decision on what medicine to prescribe to
the children was largely based on their training and the
stipulations in the standard treatment guidelines and
depending on drug availability.
A medical doctor provided supervision on clinical aspects
of patient management, a biomedical scientist supervised
diagnostic procedures and the scientific officers provided
oversight on the smooth running of the project and adher-
ence to complete and correct reporting of all patients.
All data on patients age, complaint, diagnosis and pre-
scription was recorded in the patient registers. The labora-
tory also kept a daily log sheet of all patients seen at the
laboratory. The treatment outcome was finally recorded
once the patient reached the endpoint in the study.
Retrospective parasite data for the facility from 2003 to
2008 was also reviewed in order to understand trends in
parasite prevalence over the years.
Data entry and analysis
The data was entered and analysed in Microsoft Office
Excel 2007. Data was entered by data clerks with a clinical
background to ensure that all information was well
entered. The clinical officer and scientific officer provided
supervision to the data entry clerk. The entries were veri-
fied and corrections made on a record by record basis. Fre-
quencies were generated for the parameters under
investigation. The analysis included generation of disease
burden, prescription practices and patient treatment out-
come.
The study was approved by the Ethics Committee of the
Tropical Disease Research Centre. Patient data was
recorded by study numbers. All information was kept by
the project staff. However, the study was also obliged to
provide accurate reports to the facility HMIS to ensure that
no cases were missed when the facility was reporting on
the indicators required.
Results
Malaria burden
The number of children under five who sought care from
the facility between December 2007 and February 2008
was 1,383. These children came from the different regions
of the catchment area of Chongwe rural health centre in
Chongwe district. However, five children were excluded
from analysis as there was no record of their reason for vis-
iting the health facility, leaving a total analysable sample
of 1,378. The average age for children visiting the health
facility was 20.4 months (about one year and six months).
The average temperature for all visits was 38.0°C.Malaria Journal 2009, 8:49 http://www.malariajournal.com/content/8/1/49
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Of the 1,378 children under five years, who were enrolled
or visited the health facility, 0.7% (10/1378) were found
positive for malaria and treated with artemether-lumefan-
trine (the first-line treatment for Zambia). 15 children
who were negative for malaria were also treated with anti-
malarials (13 received artemether-lumefantrine, while
two received sulphadoxine-pyrimethamine). The two
children who were treated with SP were three and seven
months old, respectively. Thus, 1.8% children were
treated with an anti-malarial (25/1378) regardless of their
malaria status. The average temperature for patients with
malaria was 39.0°C (range 37.5°C to 40.2°C) and the
average age was 30 months (range 12 to 58 months).
A sample of 200 slides was taken for validation by two
independent laboratory technicians. There was no disa-
greement with the result of the test for both positive and
negative rapid diagnostic test result. The RDT used was the
histidine-rich protein II (HRP-2) type, ICT Mal Pf. by ICT
Diagnostics of South Africa.
Microscopy examination of the 10 positive slides did not
show any mixed infections, only mono infections with
Plasmodium falciparum were detected. Further, none of the
patients who reported to the health facility had severe
malaria and no deaths due to malaria were reported dur-
ing the study period. Table 1 outlines the monthly visits
and malaria parasite rates. More visits were reported in
January due to high cases of skin infections and non-
bloody diarrhoea in three areas of Chongwe (Dam area,
Township and Libuko) in January alone.
Causes of outpatient visits
Acute respiratory infections (ARI) non-pneumonia
(42.5%) and pneumonia (5.7%) were among the top five
causes of morbidity at the facility. Malaria was not even
among the top 10 causes of visitation at this facility
(ranked number 15 (0.7%). Among the least causes of
morbidity were diseases such as one case of tuberculosis
(29 months) and one case of chicken pox was reported in
the three months. Fever of unknown origin was found in
20 patients (1.5%), however, these patients were treated
with paracetamol and no further complaints were
received from parents or caretakers within the 14 days of
follow up. Another 34 children (2.5%) were found not to
have any illness and therefore did not need to visit the
facility at all. However, they were treated with either para-
cetamol or some antibiotics.
Referrals
A total of five children were referred for further manage-
ment to the University Teaching Hospital. The referrals
included one each for skin infection, severe malnutrition,
fractured arm, conjunctivitis and the only case of tubercu-
losis. Three children were locally admitted at the health
centre, two for pneumonia and one for severe diarrhoea.
Treatment characteristics
Piriton was mostly prescribed than all the treatments as
shown in table 2. Amoxyl was the most prescribed antibi-
otic (20%), followed by septrin (10.5%) and pen V
(9.1%). Anti-malarials were prescribed in less than 2% of
the patients, 23 patients were treated with Coartem® (arte-
mether-lumefantrine) and two with Fansidar® (SP). All the
patients treated with anti-malarials were not prescribed an
antibiotic, but paracetamol as per standard treatment
guidelines for patients with no concomitant illness. Other
drugs included treatment for burns, sprain, worms, etc.
About 23.4% (323/1378) of all patients were prescribed
with a single drug only. Among the 323 patients who
received a single drug, 35% were treated with paracetamol
alone, followed by Piriton®, Oral Rehydration Salts (ORS)
and Amoxyl®  respectively as shown in Table 3. Five
patients were treated with Coartem® only (1.5%).
It was also observed that 77% of all the patients were pre-
scribed at least two drugs. Paracetamol and a given treat-
ment was a common combination accounting for 79% of
the double prescriptions (prescriptions of two drugs).
None of the patients were prescribed more than one anti-
biotic. However, it is possible that some patients may
have been prescribed paracetamol in addition to the two
antibiotics and this may not have been documented.
Trends in parasite prevalence among under-five children 
with fever at OPD
The parasite prevalence among fever patients has been
reducing from a high of 83% in 2004 to 0.7% in 2008
[22]. Further, population surveys have also shown that
Table 1: Facility visits for and malaria treatment
Month Number of visits for Under-five Number positive (Parasite prevalence) Total anti-malarial treatments
December 2007 378 2 (0.53%)
95% CI [0.2–1.9]
6 (1.6%)
95% CI [0.7–3.4]
January 2008 638 7 (1.1%)
95% CI [0.5–2.2]
13 (2.0%)
95% CI [1.2–3.4]
February 2008 362 1 (0.3)%
95% CI [0.01–1.5]
6 (1.7%)
95% CI [0.8–3.4]
Total visits 1378 10 (0.7%)
95% CI [0.4–1.3]
25 (1.8%)
95% CI [1.2–2.7]Malaria Journal 2009, 8:49 http://www.malariajournal.com/content/8/1/49
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there has been a reduction in parasite prevalence among
the under-five population from household surveys from
20% in 2006 to 11% in 2008 [18,19].
Discussion
The study has shown parasite rates lower than the
national average. The health facility is situated in a district
where an integrated package for malaria control has been
implemented. The parasite prevalence at OPD was less
than 1%, only 10 confirmed cases in three months during
the rainy season. Earlier parasite survey results conducted
at the same facility in January and February 2006 among
under-five children, recorded a parasite prevalence of 28%
at OPD, 7.9% among pregnant women and 7.0% among
asymptomatic primary school children (aged 2–14 years)
at Chongwe basic school [23]. Further, in 2005, out of the
3338 all OPD visits, malaria was confirmed in 35% of all
patients with fever, while in 2006, malaria accounted for
24% of health facility visits at Chongwe rural health facil-
ity [24]. So it appears that the malaria disease burden at
Chongwe rural health facility has been on a steady decline
as shown in figure 1.
The availability of diagnostic facilities (either RDT or
microscopy) created an opportunity to correctly identify
malaria and non-malaria cases. This is an important step
in improving not only malaria management, but overall
patient management. The training which was given to the
health workers before the study seemed to have assisted
with using the diagnostic results to inform decision to pre-
scribe an anti-malarial. Previous studies in Zambia
showed that health workers still prescribed anti-malarials
to more than 50% of negative cases [25].
Respiratory infections were diagnosed in more than 40%
of the children under five years of age during the study
period. It was not possible in this study to assess the qual-
ity of these diagnoses which were made for non-malaria
fevers. However, the supervision reports for medical
supervisors showed that patients were managed as per
standard treatment guidelines. As malaria-related fever are
reduced, the management of fever in under-five children
is an area of further research to help identify gaps or doc-
ument best practices where these may exist. This also has
implications for home-management of fever using com-
munity health workers. The management of malaria and
pneumonia studies are a necessary area for implementa-
tion research involving community health workers.
As seen from the prescription practices in this study, the
use of antibiotics will increase to replace over prescription
of anti-malarials at health facility level. Therefore, system-
atic antimicrobial resistance monitoring to these drugs
should be developed. However, it was satisfying to note
that paracetamol was prescribed in cases which were
found not to need any medication as opposed to the use
of antibiotics.
This study has also demonstrated that improved case
management reduces severe malaria or severe patient out-
comes. The health facility had effective first line treatment
as per treatment policy in Zambia and diagnostic tools
were readily available not only to the laboratory techni-
cian, but also to the nurses in the screening room. There
was no severe malaria and no deaths reported among all
the under-five children. Further, none of the referrals were
malaria related. The community health worker was very
useful in patient follow ups and feedback to the facility.
Table 2: Proportion of patients treated with a named drug
Treatment Number Frequency (%)
Piriton 396 28.7
Amoxyl 274 19.9
ORS 151 11.0
Septrin 145 10.5
Pen V 125 9.1
Panadol 114 8.3
Flagyl 48 3.5
Coartem 23 1.7
Hydrocortisone 22 1.6
Nystatin 17 1.2
Phenergan 13 0.9
Cephalexin 10 0.7
Erythromycin 9 0.7
Clotrimazole 8 0.6
Procaine penicillin 7 0.5
Other 16 1.2
Total 1378
Table 3: Characteristics of single primary prescriptions
Single prescriptions Number %
Panadol 114 35.3
Prirton 63 19.5
ORS 40 12.4
Amoxyl 36 11.1
Pen V 23 7.1
TEO 14 4.3
Septrin 12 3.7
Phernergan 5 1.5
Coartem® 51 . 5
Cefalexin 4 1.2
Ciproflaxin 4 1.2
TSO 1 0.3
X-Pen 1 0.3
Griseofulvin 1 0.3
Total 323Malaria Journal 2009, 8:49 http://www.malariajournal.com/content/8/1/49
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Some of the observation from this study is that the health
system stands to potentially benefit from integrated
malaria control through reduced malaria related revisits,
reduced referrals, reduction in anti-malarial needs and in
the long run reduction in health worker work load. How-
ever, the magnitude of these benefits need to be quanti-
fied by economic studies. Other studies in Africa have
shown that rapidly scaling up coverage of effective treat-
ment and vector control reduces malaria morbidity and
mortality as shown in South Africa [26] and Zanzibar
[27].
The study findings also seem to challenge the widely used
indicator: "proportion of children with fever who received
an anti-malarial". From this study, one could see that very
few patients with fever were prescribed an anti-malarial
because they really did not need to. So the indicator as it
stands is of little use for programme managers and district
personnel. However, it is important to measure among
the "true malaria" cases, how many received an anti-
malarial (or ACT). This will be important as more and
more diagnostics are being scaled-up.
Implementing integrated malaria control implies invest-
ing in changing health worker prescription practices based
on evidence based development of treatment guidelines.
The study's main limitation is the lack of assessment of
the accuracy of non-malaria diagnoses. However, as can
be seen from the study there were no adverse health out-
comes.
Conclusion
Implementing integrated malaria control has the poten-
tial to reduce malaria related visits at the health facility.
However, respiratory infections are still prevalent. These
findings have implications for the management of non-
malaria fevers in children under the age of five years. Man-
agement of fever in under-five children needs updating
based on the changes in epidemiology. As malaria will no
longer be the suspect, potential mismanagement of non-
malaria fevers is an important area of research. Improved
health facility surveillance will be useful in redefining dis-
ease priorities in a given locality.
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